公开(公告)号：US07083910B2

公开(公告)日：2006-08-01

申请号：US10911978

申请日：2004-08-04

申请人： David Lucas ,  Raleigh Carmen

发明人： David Lucas ,  Raleigh Carmen

IPC分类号： A01N1/02

CPC分类号： A01N1/02 ,  A01N1/0221

摘要： Methods and compositions for preserving blood platelet suspensions which can be stored and preserved for extended periods of time are provided herein. The methods and compositions employ a mixture comprising blood platelets and one or more citrate salts. Such blood platelet mixtures may be cooled either rapidly or slowly and stored for several days prior to use in patients.

摘要翻译： 本文提供了可以长期储存和保存的血小板悬浮液的保存方法和组合物。 方法和组合物使用包含血小板和一种或多种柠檬酸盐的混合物。 这样的血小板混合物可以快速或缓慢地冷却，并在用于患者之前储存数天。

公开(公告)号：US20050064381A1

公开(公告)日：2005-03-24

申请号：US10911978

申请日：2004-08-04

申请人： David Lucas ,  Raleigh Carmen

发明人： David Lucas ,  Raleigh Carmen

IPC分类号： A01N20060101 ,  A01N1/00 ,  A01N1/02

CPC分类号： A01N1/02 ,  A01N1/0221

摘要： Methods and compositions for preserving blood platelet suspensions which can be stored and preserved for extended periods of time are provided herein. The methods and compositions employ a mixture comprising blood platelets and one or more citrate salts. Such blood platelet mixtures may be cooled either rapidly or slowly and stored for several days prior to use in patients.

摘要翻译： 本文提供了可以长期储存和保存的血小板悬浮液的保存方法和组合物。 方法和组合物使用包含血小板和一种或多种柠檬酸盐的混合物。 这样的血小板混合物可以快速或缓慢地冷却，并在用于患者之前储存数天。

公开(公告)号：US5240829A

公开(公告)日：1993-08-31

申请号：US309445

申请日：1989-02-10

申请人： Raleigh Carmen ,  Chi-Yong Chong

发明人： Raleigh Carmen ,  Chi-Yong Chong

IPC分类号： A61J1/05 ,  A61J1/10 ,  A61L2/00 ,  A61L2/20 ,  A61M1/02 ,  A61M1/36

CPC分类号： A61M1/0209 ,  A61L2/0094 ,  A61L2/20 ,  A61M1/0218 ,  A61M1/3687

摘要： A closed system for inactivating viruses in blood or blood components. The system includes at least one plastic bag which communicates with a separate container including a single viricidal substance or separate substances which, when mixed, provide in situgeneration of a viricidal substance. The viricidal substance can be transferred into the bag for subsequent viricidal use on blood components or for use on components in the bag. A preferred system provides a means for the in-situ generation of ClO.sub.2 from sterilizable, separate substances for viricidal use on blood or blood components.